IL178907A0 - Use of sulglicotide for the treatment of mucositis - Google Patents

Use of sulglicotide for the treatment of mucositis

Info

Publication number
IL178907A0
IL178907A0 IL178907A IL17890706A IL178907A0 IL 178907 A0 IL178907 A0 IL 178907A0 IL 178907 A IL178907 A IL 178907A IL 17890706 A IL17890706 A IL 17890706A IL 178907 A0 IL178907 A0 IL 178907A0
Authority
IL
Israel
Prior art keywords
sulglicotide
mucositis
treatment
Prior art date
Application number
IL178907A
Other languages
English (en)
Original Assignee
Gentium Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gentium Spa filed Critical Gentium Spa
Publication of IL178907A0 publication Critical patent/IL178907A0/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00General protective or antinoxious agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Toxicology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
IL178907A 2004-05-18 2006-10-26 Use of sulglicotide for the treatment of mucositis IL178907A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT000989A ITMI20040989A1 (it) 2004-05-18 2004-05-18 Uso del sulglicotide per iul trattamento delle mucositi
PCT/IT2005/000272 WO2005110458A1 (en) 2004-05-18 2005-05-12 Use of sulglicotide for the treatement of mucositis

Publications (1)

Publication Number Publication Date
IL178907A0 true IL178907A0 (en) 2007-03-08

Family

ID=34971240

Family Applications (1)

Application Number Title Priority Date Filing Date
IL178907A IL178907A0 (en) 2004-05-18 2006-10-26 Use of sulglicotide for the treatment of mucositis

Country Status (9)

Country Link
US (1) US7662777B2 (https=)
EP (1) EP1747010B1 (https=)
JP (1) JP4874962B2 (https=)
CN (1) CN1972705B (https=)
BR (1) BRPI0511165A (https=)
CA (1) CA2565084C (https=)
IL (1) IL178907A0 (https=)
IT (1) ITMI20040989A1 (https=)
WO (1) WO2005110458A1 (https=)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101851285B (zh) * 2009-04-03 2012-09-12 四川德博尔制药有限公司 硫酸糖肽的制备方法
KR101819709B1 (ko) * 2017-01-13 2018-01-17 (주)아이엠디팜 설글리코타이드 또는 이의 약학적으로 허용가능한 염을 포함하는 안구건조증의 예방 또는 치료용 약학 조성물
KR102863615B1 (ko) * 2022-07-11 2025-09-24 삼일제약 주식회사 생체이용률이 개선된 설글리코타이드를 유효성분으로 포함하는 염증성 질환의 예방 또는 치료용 약제학적 조성물 및 그 제조방법
CN115845127B (zh) * 2022-12-29 2023-11-24 海南众森生物科技有限公司 一种多糖止血修复生物胶液及其制备方法和用途
CN116440036B (zh) * 2023-04-12 2024-10-29 燕园同创生物科技(北京)有限公司 一种修复美白护龈固齿牙膏及其制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1215332B (it) 1987-01-12 1990-02-08 Crinos Industria Farmaco Composizione farmaceutica contenente sulglicotide per la terapia dell'ulcera gastrica
WO1992018153A1 (en) 1991-04-12 1992-10-29 Creative Biomolecules, Inc. Method of treating gastrointestinal ulcers with platelet derived growth factor
US5496828A (en) 1994-08-22 1996-03-05 Eli Lilly And Company Methods of inhibiting ulcerative mucositis
WO2003024391A2 (en) * 2001-08-16 2003-03-27 Mucosal Therapeutics, Inc. Treatment and prevention of mucositis in cancer patients
AU2003230952A1 (en) * 2002-05-21 2003-12-12 Abbott Laboratories Treatment of mucositis

Also Published As

Publication number Publication date
EP1747010B1 (en) 2015-01-21
US20080234180A1 (en) 2008-09-25
JP2007538066A (ja) 2007-12-27
CN1972705A (zh) 2007-05-30
EP1747010A1 (en) 2007-01-31
JP4874962B2 (ja) 2012-02-15
BRPI0511165A (pt) 2007-12-04
ITMI20040989A1 (it) 2004-08-18
US7662777B2 (en) 2010-02-16
WO2005110458A1 (en) 2005-11-24
CN1972705B (zh) 2011-11-02
CA2565084A1 (en) 2005-11-24
CA2565084C (en) 2013-09-03

Similar Documents

Publication Publication Date Title
PT3424932T (pt) Boronoftalidas para utilização terapêutica
EP1809265A4 (en) METHOD FOR THE TREATMENT OF SYNNUCLEOPATHIES
IL178827A0 (en) Use of reboxetine for the treatment of pain
PL1945243T3 (pl) Zastosowanie kalcytoniny w leczeniu rzs
DK2392335T3 (en) Use of 24-norUDCA
EP1888056A4 (en) USE OF LADOSTIGIL FOR TREATING MULTIPLE SCLEROSIS
GB0400802D0 (en) Compounds for the treatment of disease
GB2430002B (en) Well treatment
GB0415181D0 (en) Compounds for use in the treatment of infection
IL178907A0 (en) Use of sulglicotide for the treatment of mucositis
GB0426141D0 (en) Treatment
GB0525540D0 (en) New treatment
GB0511769D0 (en) Treatment
GB0424085D0 (en) Well treatment
GB0501655D0 (en) Therapeutic use
GB0701549D0 (en) Skin treatment
GB0501476D0 (en) Treatment for mucositis
ZA200606780B (en) Compounds for the treatment of diseases
GB0505203D0 (en) Skin composition treatment
TJ20050863A (en) The way of narcotism treatment
GB0412262D0 (en) Use of compounds for the treatment of pain
GB0418556D0 (en) The treatment of pain
GB0415267D0 (en) The treatment of pain
HU0400952D0 (en) Treatment of anus-cancer
ZA200410080B (en) Composition for the treatment of humans

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees